BioWorld MedTech

Nov. 17, 2011

AHA notebook: Berlin Heart unveils favorable data from Excor clinical trial

The Berlin Heart Group (Woodlands, Texas/Berlin) unveiled clinical trial data presented yesterday at the "Scientific Sessions 2011" annual meeting of the American Heart Association (AHA; Washington). Read More

CooperVision recall expanded, management credibility hit

International report: Boston Sci's Watchman implanted in first Latin American patients

Washington roundup: FDA spells out new staged IDE approval in new draft guidance

Financings roundup: Unilife prices offering, expects to raise $34M

Deals roundup: AptarGroup acquires minority interest in OVal for $3.2M

Agreements/contracts: Genisphere to supply RNA technology to Affymetrix

New ventures: Optum launches institute for sustainable health

Med-Tech Notes: Digital Assent opens more offices

HIT roundup: Methodist Hospital to deploy SciQuest's eMarketplace

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...